Volatile organic compounds in exhaled breath for the detection of interstitial lung disease (VISION)

Volatile organic compounds in exhaled breath for the detection of interstitial lung disease (VISION) - VISION

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52688

Enrollment

180

Registered

2020-10-08

Start date

2020-11-04

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung fibrosis

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Eligible for participation in this study are all patients (>= 18 years of age): - with a known diagnosis of ILD (based on high resolution chest CT obtained in usual care) - at risk for ILD (based on suspected diagnosis, chest X-ray, complaints or abnormal lung function obtained in usual care) - without ILD (other diagnosis)

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Recent (

Design outcomes

Primary

Measure	Time frame
To determine the diagnostic accuracy of exhaled breath analysis by eNose at point of care for discrimination between patients with ILD,at risk for ILD (including post COVID-19 patients) and without ILD.	—

Secondary

Measure	Time frame
To assess the accuracy of exhaled breath analysis by eNose at baseline and follow-up to identify diagnostic markers for early diagnosis and disease progression of ILD.	—

Countries

Netherlands

Outcome results